The platelet-derived growth factor receptor beta (PDGFRB) has been shown to contribute to Ewing sarcoma growth and metastasis in vitro and in vivo [36, 37] and demonstrated the most prominent activation upon plerixafor treatment in A673 CXCR4-low cells (Fig. 5b). The gene discussed is PDGFRB; the disease is Ewing sarcoma.